Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study
Frontiers in Pharmacology · 07.06.2024 · 15
DOI: 10.3389/fphar.2024.1389808 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.06.2024. Verfasst von Lin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin University of Traditional Chinese Medicine, Tianjin, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
The impact of the Standard Protocol Items: Recommendations for Interventional Trials of Traditional Chinese Medicine (SPIRIT-TCM) Extension 2018 statement on the reporting quality of randomized controlled trial (RCT) protocols in traditional Chinese medicine (TCM) is not clear. This review aimed to assess the reporting characteristics and quality of RCT protocols involving interventions such as Chinese herbal medicine formulas (CHMF), acupuncture, and moxibustion published in the last 3 years.
Methods
We conducted an extensive search among multiple databases, including All EBM Reviews, Allied and Complementary Medicine (AMED), Embase, Ovid MEDLINE(R), PubMed, Web of Science, Google Scholar, and ClinicalTrials.gov for publications in English from 1 January 2020 to 10 August 2023. Two reviewers independently assessed the eligibility of the publications, extracted predetermined information, and evaluated the reporting based on the SPIRIT-TCM Extension 2018 checklist.
Results
Of the 420 eligible protocols (comprising 163 studies on CHMF, 239 on acupuncture, and 18 on moxibustion), the average reporting compliance rate was only 35.4%. Approximately half of the assessed items fell into the category of poorly reported, demonstrating a compliance rate below 65%. Notably, reporting compliance in acupuncture and moxibustion interventional studies exhibited higher scores than compliance in CHMF studies.
Conclusion
Continued, concerted, and coordinated efforts are required by journals, editors, reviewers, and investigators to improve the application and promotion of the SPIRIT-TCM Extension 2018 reporting guideline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Chinese EQUATOR Centre, Hong Kong Baptist University, Kowloon, China.
- Guangdong Provincial Hospital of Chinese Medicine in Guizhou, Guizhou, China.
- School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China.
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University, Kowloon, China.
- Centre for Chinese Herbal Medicine Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, China.
Zitieren
APA
Zhang, L., Li, H., Hu, L., Ou, X., Tan, H., Zhang, X., Lau, C. T., Lyu, A., Bian, Z., & Zhang, X. (2024). Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1389808
Vancouver
Zhang L, Li H, Hu L, Ou X, Tan H, Zhang X, et al. Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1389808
BibTeX
@article{Zhang2024,
author = {Zhang, Lin and Li, Han and Hu, Lihan and Ou, Xiangqin and Tan, Hanzhi and Zhang, Xuanqi and Lau, Chung Tai and Lyu, Aiping and Bian, Zhaoxiang and Zhang, Xuan},
title = {Reporting characteristics and quality of randomized controlled trial protocols in traditional Chinese medicine: a cross-sectional study},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1389808}
}
EUVIMED